ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge

August 16, 1985

Clinical Research: Cooperative Groups Form Coalition to Advance Trials

November 14, 1997

Community Center Group To Consider “Clinical Standards, Medical Audit”

September 13, 1974

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014